Global Medicinal Radiocompounds Supply, Demand and Key Producers, 2023-2029

Global Medicinal Radiocompounds Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 30 Aug 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Medicinal Radiocompounds market size is expected to reach $ 11810 million by 2029, rising at a market growth of 7.8% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Medicinal Radiocompounds refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Medicinal Radiocompounds are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

This report studies the global Medicinal Radiocompounds production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medicinal Radiocompounds, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medicinal Radiocompounds that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medicinal Radiocompounds total production and demand, 2018-2029, (Tons)
Global Medicinal Radiocompounds total production value, 2018-2029, (USD Million)
Global Medicinal Radiocompounds production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Medicinal Radiocompounds consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Medicinal Radiocompounds domestic production, consumption, key domestic manufacturers and share
Global Medicinal Radiocompounds production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Medicinal Radiocompounds production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Medicinal Radiocompounds production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).

This reports profiles key players in the global Medicinal Radiocompounds market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, Novartis, Lantheus, Acrotech Biopharma, GE Healthcare and China Isotope & Radiation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medicinal Radiocompounds market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medicinal Radiocompounds Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Medicinal Radiocompounds Market, Segmentation by Type
Technetium 99
Fluorine 18
Other

Global Medicinal Radiocompounds Market, Segmentation by Application
Oncology
Cardiology
Others

Companies Profiled:
Bracco Imaging
Bayer
Cardinal Health
Curium Pharma
Novartis
Lantheus
Acrotech Biopharma
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
SIEMENS
Dongcheng

Key Questions Answered
1. How big is the global Medicinal Radiocompounds market?
2. What is the demand of the global Medicinal Radiocompounds market?
3. What is the year over year growth of the global Medicinal Radiocompounds market?
4. What is the production and production value of the global Medicinal Radiocompounds market?
5. Who are the key producers in the global Medicinal Radiocompounds market?
btl

Table of Contents

1 Supply Summary
1.1 Medicinal Radiocompounds Introduction
1.2 World Medicinal Radiocompounds Supply & Forecast
1.2.1 World Medicinal Radiocompounds Production Value (2018 & 2022 & 2029)
1.2.2 World Medicinal Radiocompounds Production (2018-2029)
1.2.3 World Medicinal Radiocompounds Pricing Trends (2018-2029)
1.3 World Medicinal Radiocompounds Production by Region (Based on Production Site)
1.3.1 World Medicinal Radiocompounds Production Value by Region (2018-2029)
1.3.2 World Medicinal Radiocompounds Production by Region (2018-2029)
1.3.3 World Medicinal Radiocompounds Average Price by Region (2018-2029)
1.3.4 North America Medicinal Radiocompounds Production (2018-2029)
1.3.5 Europe Medicinal Radiocompounds Production (2018-2029)
1.3.6 China Medicinal Radiocompounds Production (2018-2029)
1.3.7 Japan Medicinal Radiocompounds Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medicinal Radiocompounds Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medicinal Radiocompounds Major Market Trends

2 Demand Summary
2.1 World Medicinal Radiocompounds Demand (2018-2029)
2.2 World Medicinal Radiocompounds Consumption by Region
2.2.1 World Medicinal Radiocompounds Consumption by Region (2018-2023)
2.2.2 World Medicinal Radiocompounds Consumption Forecast by Region (2024-2029)
2.3 United States Medicinal Radiocompounds Consumption (2018-2029)
2.4 China Medicinal Radiocompounds Consumption (2018-2029)
2.5 Europe Medicinal Radiocompounds Consumption (2018-2029)
2.6 Japan Medicinal Radiocompounds Consumption (2018-2029)
2.7 South Korea Medicinal Radiocompounds Consumption (2018-2029)
2.8 ASEAN Medicinal Radiocompounds Consumption (2018-2029)
2.9 India Medicinal Radiocompounds Consumption (2018-2029)

3 World Medicinal Radiocompounds Manufacturers Competitive Analysis
3.1 World Medicinal Radiocompounds Production Value by Manufacturer (2018-2023)
3.2 World Medicinal Radiocompounds Production by Manufacturer (2018-2023)
3.3 World Medicinal Radiocompounds Average Price by Manufacturer (2018-2023)
3.4 Medicinal Radiocompounds Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medicinal Radiocompounds Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medicinal Radiocompounds in 2022
3.5.3 Global Concentration Ratios (CR8) for Medicinal Radiocompounds in 2022
3.6 Medicinal Radiocompounds Market: Overall Company Footprint Analysis
3.6.1 Medicinal Radiocompounds Market: Region Footprint
3.6.2 Medicinal Radiocompounds Market: Company Product Type Footprint
3.6.3 Medicinal Radiocompounds Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Medicinal Radiocompounds Production Value Comparison
4.1.1 United States VS China: Medicinal Radiocompounds Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Medicinal Radiocompounds Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Medicinal Radiocompounds Production Comparison
4.2.1 United States VS China: Medicinal Radiocompounds Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medicinal Radiocompounds Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Medicinal Radiocompounds Consumption Comparison
4.3.1 United States VS China: Medicinal Radiocompounds Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Medicinal Radiocompounds Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Medicinal Radiocompounds Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medicinal Radiocompounds Production Value (2018-2023)
4.4.3 United States Based Manufacturers Medicinal Radiocompounds Production (2018-2023)
4.5 China Based Medicinal Radiocompounds Manufacturers and Market Share
4.5.1 China Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medicinal Radiocompounds Production Value (2018-2023)
4.5.3 China Based Manufacturers Medicinal Radiocompounds Production (2018-2023)
4.6 Rest of World Based Medicinal Radiocompounds Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medicinal Radiocompounds Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Medicinal Radiocompounds Production (2018-2023)

5 Market Analysis by Type
5.1 World Medicinal Radiocompounds Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Technetium 99
5.2.2 Fluorine 18
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Medicinal Radiocompounds Production by Type (2018-2029)
5.3.2 World Medicinal Radiocompounds Production Value by Type (2018-2029)
5.3.3 World Medicinal Radiocompounds Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Medicinal Radiocompounds Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Medicinal Radiocompounds Production by Application (2018-2029)
6.3.2 World Medicinal Radiocompounds Production Value by Application (2018-2029)
6.3.3 World Medicinal Radiocompounds Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Details
7.1.2 Bracco Imaging Major Business
7.1.3 Bracco Imaging Medicinal Radiocompounds Product and Services
7.1.4 Bracco Imaging Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bracco Imaging Recent Developments/Updates
7.1.6 Bracco Imaging Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Medicinal Radiocompounds Product and Services
7.2.4 Bayer Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Cardinal Health
7.3.1 Cardinal Health Details
7.3.2 Cardinal Health Major Business
7.3.3 Cardinal Health Medicinal Radiocompounds Product and Services
7.3.4 Cardinal Health Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health Recent Developments/Updates
7.3.6 Cardinal Health Competitive Strengths & Weaknesses
7.4 Curium Pharma
7.4.1 Curium Pharma Details
7.4.2 Curium Pharma Major Business
7.4.3 Curium Pharma Medicinal Radiocompounds Product and Services
7.4.4 Curium Pharma Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Curium Pharma Recent Developments/Updates
7.4.6 Curium Pharma Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Medicinal Radiocompounds Product and Services
7.5.4 Novartis Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Lantheus
7.6.1 Lantheus Details
7.6.2 Lantheus Major Business
7.6.3 Lantheus Medicinal Radiocompounds Product and Services
7.6.4 Lantheus Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lantheus Recent Developments/Updates
7.6.6 Lantheus Competitive Strengths & Weaknesses
7.7 Acrotech Biopharma
7.7.1 Acrotech Biopharma Details
7.7.2 Acrotech Biopharma Major Business
7.7.3 Acrotech Biopharma Medicinal Radiocompounds Product and Services
7.7.4 Acrotech Biopharma Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Acrotech Biopharma Recent Developments/Updates
7.7.6 Acrotech Biopharma Competitive Strengths & Weaknesses
7.8 GE Healthcare
7.8.1 GE Healthcare Details
7.8.2 GE Healthcare Major Business
7.8.3 GE Healthcare Medicinal Radiocompounds Product and Services
7.8.4 GE Healthcare Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GE Healthcare Recent Developments/Updates
7.8.6 GE Healthcare Competitive Strengths & Weaknesses
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Details
7.9.2 China Isotope & Radiation Major Business
7.9.3 China Isotope & Radiation Medicinal Radiocompounds Product and Services
7.9.4 China Isotope & Radiation Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Details
7.10.2 Jubilant Pharma Major Business
7.10.3 Jubilant Pharma Medicinal Radiocompounds Product and Services
7.10.4 Jubilant Pharma Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jubilant Pharma Recent Developments/Updates
7.10.6 Jubilant Pharma Competitive Strengths & Weaknesses
7.11 Eli Lilly
7.11.1 Eli Lilly Details
7.11.2 Eli Lilly Major Business
7.11.3 Eli Lilly Medicinal Radiocompounds Product and Services
7.11.4 Eli Lilly Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Eli Lilly Recent Developments/Updates
7.11.6 Eli Lilly Competitive Strengths & Weaknesses
7.12 SIEMENS
7.12.1 SIEMENS Details
7.12.2 SIEMENS Major Business
7.12.3 SIEMENS Medicinal Radiocompounds Product and Services
7.12.4 SIEMENS Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 SIEMENS Recent Developments/Updates
7.12.6 SIEMENS Competitive Strengths & Weaknesses
7.13 Dongcheng
7.13.1 Dongcheng Details
7.13.2 Dongcheng Major Business
7.13.3 Dongcheng Medicinal Radiocompounds Product and Services
7.13.4 Dongcheng Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Dongcheng Recent Developments/Updates
7.13.6 Dongcheng Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Medicinal Radiocompounds Industry Chain
8.2 Medicinal Radiocompounds Upstream Analysis
8.2.1 Medicinal Radiocompounds Core Raw Materials
8.2.2 Main Manufacturers of Medicinal Radiocompounds Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Medicinal Radiocompounds Production Mode
8.6 Medicinal Radiocompounds Procurement Model
8.7 Medicinal Radiocompounds Industry Sales Model and Sales Channels
8.7.1 Medicinal Radiocompounds Sales Model
8.7.2 Medicinal Radiocompounds Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Medicinal Radiocompounds Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Medicinal Radiocompounds Production Value by Region (2018-2023) & (USD Million)
Table 3. World Medicinal Radiocompounds Production Value by Region (2024-2029) & (USD Million)
Table 4. World Medicinal Radiocompounds Production Value Market Share by Region (2018-2023)
Table 5. World Medicinal Radiocompounds Production Value Market Share by Region (2024-2029)
Table 6. World Medicinal Radiocompounds Production by Region (2018-2023) & (Tons)
Table 7. World Medicinal Radiocompounds Production by Region (2024-2029) & (Tons)
Table 8. World Medicinal Radiocompounds Production Market Share by Region (2018-2023)
Table 9. World Medicinal Radiocompounds Production Market Share by Region (2024-2029)
Table 10. World Medicinal Radiocompounds Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Medicinal Radiocompounds Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Medicinal Radiocompounds Major Market Trends
Table 13. World Medicinal Radiocompounds Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Medicinal Radiocompounds Consumption by Region (2018-2023) & (Tons)
Table 15. World Medicinal Radiocompounds Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Medicinal Radiocompounds Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Medicinal Radiocompounds Producers in 2022
Table 18. World Medicinal Radiocompounds Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Medicinal Radiocompounds Producers in 2022
Table 20. World Medicinal Radiocompounds Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Medicinal Radiocompounds Company Evaluation Quadrant
Table 22. World Medicinal Radiocompounds Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Medicinal Radiocompounds Production Site of Key Manufacturer
Table 24. Medicinal Radiocompounds Market: Company Product Type Footprint
Table 25. Medicinal Radiocompounds Market: Company Product Application Footprint
Table 26. Medicinal Radiocompounds Competitive Factors
Table 27. Medicinal Radiocompounds New Entrant and Capacity Expansion Plans
Table 28. Medicinal Radiocompounds Mergers & Acquisitions Activity
Table 29. United States VS China Medicinal Radiocompounds Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Medicinal Radiocompounds Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Medicinal Radiocompounds Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Medicinal Radiocompounds Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Medicinal Radiocompounds Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Medicinal Radiocompounds Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Medicinal Radiocompounds Production Market Share (2018-2023)
Table 37. China Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Medicinal Radiocompounds Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Medicinal Radiocompounds Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Medicinal Radiocompounds Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Medicinal Radiocompounds Production Market Share (2018-2023)
Table 42. Rest of World Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Medicinal Radiocompounds Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Medicinal Radiocompounds Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Medicinal Radiocompounds Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Medicinal Radiocompounds Production Market Share (2018-2023)
Table 47. World Medicinal Radiocompounds Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Medicinal Radiocompounds Production by Type (2018-2023) & (Tons)
Table 49. World Medicinal Radiocompounds Production by Type (2024-2029) & (Tons)
Table 50. World Medicinal Radiocompounds Production Value by Type (2018-2023) & (USD Million)
Table 51. World Medicinal Radiocompounds Production Value by Type (2024-2029) & (USD Million)
Table 52. World Medicinal Radiocompounds Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Medicinal Radiocompounds Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Medicinal Radiocompounds Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Medicinal Radiocompounds Production by Application (2018-2023) & (Tons)
Table 56. World Medicinal Radiocompounds Production by Application (2024-2029) & (Tons)
Table 57. World Medicinal Radiocompounds Production Value by Application (2018-2023) & (USD Million)
Table 58. World Medicinal Radiocompounds Production Value by Application (2024-2029) & (USD Million)
Table 59. World Medicinal Radiocompounds Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Medicinal Radiocompounds Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 62. Bracco Imaging Major Business
Table 63. Bracco Imaging Medicinal Radiocompounds Product and Services
Table 64. Bracco Imaging Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bracco Imaging Recent Developments/Updates
Table 66. Bracco Imaging Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Medicinal Radiocompounds Product and Services
Table 70. Bayer Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health Major Business
Table 75. Cardinal Health Medicinal Radiocompounds Product and Services
Table 76. Cardinal Health Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health Recent Developments/Updates
Table 78. Cardinal Health Competitive Strengths & Weaknesses
Table 79. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Curium Pharma Major Business
Table 81. Curium Pharma Medicinal Radiocompounds Product and Services
Table 82. Curium Pharma Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Curium Pharma Recent Developments/Updates
Table 84. Curium Pharma Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Medicinal Radiocompounds Product and Services
Table 88. Novartis Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Lantheus Basic Information, Manufacturing Base and Competitors
Table 92. Lantheus Major Business
Table 93. Lantheus Medicinal Radiocompounds Product and Services
Table 94. Lantheus Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lantheus Recent Developments/Updates
Table 96. Lantheus Competitive Strengths & Weaknesses
Table 97. Acrotech Biopharma Basic Information, Manufacturing Base and Competitors
Table 98. Acrotech Biopharma Major Business
Table 99. Acrotech Biopharma Medicinal Radiocompounds Product and Services
Table 100. Acrotech Biopharma Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Acrotech Biopharma Recent Developments/Updates
Table 102. Acrotech Biopharma Competitive Strengths & Weaknesses
Table 103. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. GE Healthcare Major Business
Table 105. GE Healthcare Medicinal Radiocompounds Product and Services
Table 106. GE Healthcare Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GE Healthcare Recent Developments/Updates
Table 108. GE Healthcare Competitive Strengths & Weaknesses
Table 109. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 110. China Isotope & Radiation Major Business
Table 111. China Isotope & Radiation Medicinal Radiocompounds Product and Services
Table 112. China Isotope & Radiation Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Isotope & Radiation Recent Developments/Updates
Table 114. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 115. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Jubilant Pharma Major Business
Table 117. Jubilant Pharma Medicinal Radiocompounds Product and Services
Table 118. Jubilant Pharma Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jubilant Pharma Recent Developments/Updates
Table 120. Jubilant Pharma Competitive Strengths & Weaknesses
Table 121. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 122. Eli Lilly Major Business
Table 123. Eli Lilly Medicinal Radiocompounds Product and Services
Table 124. Eli Lilly Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Eli Lilly Recent Developments/Updates
Table 126. Eli Lilly Competitive Strengths & Weaknesses
Table 127. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 128. SIEMENS Major Business
Table 129. SIEMENS Medicinal Radiocompounds Product and Services
Table 130. SIEMENS Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. SIEMENS Recent Developments/Updates
Table 132. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 133. Dongcheng Major Business
Table 134. Dongcheng Medicinal Radiocompounds Product and Services
Table 135. Dongcheng Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Medicinal Radiocompounds Upstream (Raw Materials)
Table 137. Medicinal Radiocompounds Typical Customers
Table 138. Medicinal Radiocompounds Typical Distributors
List of Figure
Figure 1. Medicinal Radiocompounds Picture
Figure 2. World Medicinal Radiocompounds Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medicinal Radiocompounds Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 5. World Medicinal Radiocompounds Average Price (2018-2029) & (US$/Ton)
Figure 6. World Medicinal Radiocompounds Production Value Market Share by Region (2018-2029)
Figure 7. World Medicinal Radiocompounds Production Market Share by Region (2018-2029)
Figure 8. North America Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 9. Europe Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 10. China Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 11. Japan Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 12. Medicinal Radiocompounds Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 15. World Medicinal Radiocompounds Consumption Market Share by Region (2018-2029)
Figure 16. United States Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 17. China Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 18. Europe Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 19. Japan Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 20. South Korea Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 22. India Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Medicinal Radiocompounds by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Medicinal Radiocompounds Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Medicinal Radiocompounds Markets in 2022
Figure 26. United States VS China: Medicinal Radiocompounds Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Medicinal Radiocompounds Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medicinal Radiocompounds Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Medicinal Radiocompounds Production Market Share 2022
Figure 30. China Based Manufacturers Medicinal Radiocompounds Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Medicinal Radiocompounds Production Market Share 2022
Figure 32. World Medicinal Radiocompounds Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Medicinal Radiocompounds Production Value Market Share by Type in 2022
Figure 34. Technetium 99
Figure 35. Fluorine 18
Figure 36. Other
Figure 37. World Medicinal Radiocompounds Production Market Share by Type (2018-2029)
Figure 38. World Medicinal Radiocompounds Production Value Market Share by Type (2018-2029)
Figure 39. World Medicinal Radiocompounds Average Price by Type (2018-2029) & (US$/Ton)
Figure 40. World Medicinal Radiocompounds Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Medicinal Radiocompounds Production Value Market Share by Application in 2022
Figure 42. Oncology
Figure 43. Cardiology
Figure 44. Others
Figure 45. World Medicinal Radiocompounds Production Market Share by Application (2018-2029)
Figure 46. World Medicinal Radiocompounds Production Value Market Share by Application (2018-2029)
Figure 47. World Medicinal Radiocompounds Average Price by Application (2018-2029) & (US$/Ton)
Figure 48. Medicinal Radiocompounds Industry Chain
Figure 49. Medicinal Radiocompounds Procurement Model
Figure 50. Medicinal Radiocompounds Sales Model
Figure 51. Medicinal Radiocompounds Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bracco Imaging
Bayer
Cardinal Health
Curium Pharma
Novartis
Lantheus
Acrotech Biopharma
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
SIEMENS
Dongcheng
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Medicinal Radiocompounds Supply, Demand and Key Producers, 2023-2029

Global Medicinal Radiocompounds Supply, Demand and Key Producers, 2023-2029

Page: 107

Published Date: 30 Aug 2023

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Medicinal Radiocompounds market size is expected to reach $ 11810 million by 2029, rising at a market growth of 7.8% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Medicinal Radiocompounds refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Medicinal Radiocompounds are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

This report studies the global Medicinal Radiocompounds production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medicinal Radiocompounds, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medicinal Radiocompounds that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medicinal Radiocompounds total production and demand, 2018-2029, (Tons)
Global Medicinal Radiocompounds total production value, 2018-2029, (USD Million)
Global Medicinal Radiocompounds production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Medicinal Radiocompounds consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Medicinal Radiocompounds domestic production, consumption, key domestic manufacturers and share
Global Medicinal Radiocompounds production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Medicinal Radiocompounds production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Medicinal Radiocompounds production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).

This reports profiles key players in the global Medicinal Radiocompounds market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco Imaging, Bayer, Cardinal Health, Curium Pharma, Novartis, Lantheus, Acrotech Biopharma, GE Healthcare and China Isotope & Radiation, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medicinal Radiocompounds market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medicinal Radiocompounds Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Medicinal Radiocompounds Market, Segmentation by Type
Technetium 99
Fluorine 18
Other

Global Medicinal Radiocompounds Market, Segmentation by Application
Oncology
Cardiology
Others

Companies Profiled:
Bracco Imaging
Bayer
Cardinal Health
Curium Pharma
Novartis
Lantheus
Acrotech Biopharma
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
SIEMENS
Dongcheng

Key Questions Answered
1. How big is the global Medicinal Radiocompounds market?
2. What is the demand of the global Medicinal Radiocompounds market?
3. What is the year over year growth of the global Medicinal Radiocompounds market?
4. What is the production and production value of the global Medicinal Radiocompounds market?
5. Who are the key producers in the global Medicinal Radiocompounds market?
btl

Table of Contents

1 Supply Summary
1.1 Medicinal Radiocompounds Introduction
1.2 World Medicinal Radiocompounds Supply & Forecast
1.2.1 World Medicinal Radiocompounds Production Value (2018 & 2022 & 2029)
1.2.2 World Medicinal Radiocompounds Production (2018-2029)
1.2.3 World Medicinal Radiocompounds Pricing Trends (2018-2029)
1.3 World Medicinal Radiocompounds Production by Region (Based on Production Site)
1.3.1 World Medicinal Radiocompounds Production Value by Region (2018-2029)
1.3.2 World Medicinal Radiocompounds Production by Region (2018-2029)
1.3.3 World Medicinal Radiocompounds Average Price by Region (2018-2029)
1.3.4 North America Medicinal Radiocompounds Production (2018-2029)
1.3.5 Europe Medicinal Radiocompounds Production (2018-2029)
1.3.6 China Medicinal Radiocompounds Production (2018-2029)
1.3.7 Japan Medicinal Radiocompounds Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Medicinal Radiocompounds Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Medicinal Radiocompounds Major Market Trends

2 Demand Summary
2.1 World Medicinal Radiocompounds Demand (2018-2029)
2.2 World Medicinal Radiocompounds Consumption by Region
2.2.1 World Medicinal Radiocompounds Consumption by Region (2018-2023)
2.2.2 World Medicinal Radiocompounds Consumption Forecast by Region (2024-2029)
2.3 United States Medicinal Radiocompounds Consumption (2018-2029)
2.4 China Medicinal Radiocompounds Consumption (2018-2029)
2.5 Europe Medicinal Radiocompounds Consumption (2018-2029)
2.6 Japan Medicinal Radiocompounds Consumption (2018-2029)
2.7 South Korea Medicinal Radiocompounds Consumption (2018-2029)
2.8 ASEAN Medicinal Radiocompounds Consumption (2018-2029)
2.9 India Medicinal Radiocompounds Consumption (2018-2029)

3 World Medicinal Radiocompounds Manufacturers Competitive Analysis
3.1 World Medicinal Radiocompounds Production Value by Manufacturer (2018-2023)
3.2 World Medicinal Radiocompounds Production by Manufacturer (2018-2023)
3.3 World Medicinal Radiocompounds Average Price by Manufacturer (2018-2023)
3.4 Medicinal Radiocompounds Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Medicinal Radiocompounds Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Medicinal Radiocompounds in 2022
3.5.3 Global Concentration Ratios (CR8) for Medicinal Radiocompounds in 2022
3.6 Medicinal Radiocompounds Market: Overall Company Footprint Analysis
3.6.1 Medicinal Radiocompounds Market: Region Footprint
3.6.2 Medicinal Radiocompounds Market: Company Product Type Footprint
3.6.3 Medicinal Radiocompounds Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Medicinal Radiocompounds Production Value Comparison
4.1.1 United States VS China: Medicinal Radiocompounds Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Medicinal Radiocompounds Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Medicinal Radiocompounds Production Comparison
4.2.1 United States VS China: Medicinal Radiocompounds Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Medicinal Radiocompounds Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Medicinal Radiocompounds Consumption Comparison
4.3.1 United States VS China: Medicinal Radiocompounds Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Medicinal Radiocompounds Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Medicinal Radiocompounds Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Medicinal Radiocompounds Production Value (2018-2023)
4.4.3 United States Based Manufacturers Medicinal Radiocompounds Production (2018-2023)
4.5 China Based Medicinal Radiocompounds Manufacturers and Market Share
4.5.1 China Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Medicinal Radiocompounds Production Value (2018-2023)
4.5.3 China Based Manufacturers Medicinal Radiocompounds Production (2018-2023)
4.6 Rest of World Based Medicinal Radiocompounds Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Medicinal Radiocompounds Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Medicinal Radiocompounds Production (2018-2023)

5 Market Analysis by Type
5.1 World Medicinal Radiocompounds Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Technetium 99
5.2.2 Fluorine 18
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Medicinal Radiocompounds Production by Type (2018-2029)
5.3.2 World Medicinal Radiocompounds Production Value by Type (2018-2029)
5.3.3 World Medicinal Radiocompounds Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Medicinal Radiocompounds Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Medicinal Radiocompounds Production by Application (2018-2029)
6.3.2 World Medicinal Radiocompounds Production Value by Application (2018-2029)
6.3.3 World Medicinal Radiocompounds Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Details
7.1.2 Bracco Imaging Major Business
7.1.3 Bracco Imaging Medicinal Radiocompounds Product and Services
7.1.4 Bracco Imaging Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bracco Imaging Recent Developments/Updates
7.1.6 Bracco Imaging Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer Medicinal Radiocompounds Product and Services
7.2.4 Bayer Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Cardinal Health
7.3.1 Cardinal Health Details
7.3.2 Cardinal Health Major Business
7.3.3 Cardinal Health Medicinal Radiocompounds Product and Services
7.3.4 Cardinal Health Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Cardinal Health Recent Developments/Updates
7.3.6 Cardinal Health Competitive Strengths & Weaknesses
7.4 Curium Pharma
7.4.1 Curium Pharma Details
7.4.2 Curium Pharma Major Business
7.4.3 Curium Pharma Medicinal Radiocompounds Product and Services
7.4.4 Curium Pharma Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Curium Pharma Recent Developments/Updates
7.4.6 Curium Pharma Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Medicinal Radiocompounds Product and Services
7.5.4 Novartis Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Lantheus
7.6.1 Lantheus Details
7.6.2 Lantheus Major Business
7.6.3 Lantheus Medicinal Radiocompounds Product and Services
7.6.4 Lantheus Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Lantheus Recent Developments/Updates
7.6.6 Lantheus Competitive Strengths & Weaknesses
7.7 Acrotech Biopharma
7.7.1 Acrotech Biopharma Details
7.7.2 Acrotech Biopharma Major Business
7.7.3 Acrotech Biopharma Medicinal Radiocompounds Product and Services
7.7.4 Acrotech Biopharma Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Acrotech Biopharma Recent Developments/Updates
7.7.6 Acrotech Biopharma Competitive Strengths & Weaknesses
7.8 GE Healthcare
7.8.1 GE Healthcare Details
7.8.2 GE Healthcare Major Business
7.8.3 GE Healthcare Medicinal Radiocompounds Product and Services
7.8.4 GE Healthcare Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GE Healthcare Recent Developments/Updates
7.8.6 GE Healthcare Competitive Strengths & Weaknesses
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Details
7.9.2 China Isotope & Radiation Major Business
7.9.3 China Isotope & Radiation Medicinal Radiocompounds Product and Services
7.9.4 China Isotope & Radiation Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 China Isotope & Radiation Recent Developments/Updates
7.9.6 China Isotope & Radiation Competitive Strengths & Weaknesses
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Details
7.10.2 Jubilant Pharma Major Business
7.10.3 Jubilant Pharma Medicinal Radiocompounds Product and Services
7.10.4 Jubilant Pharma Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Jubilant Pharma Recent Developments/Updates
7.10.6 Jubilant Pharma Competitive Strengths & Weaknesses
7.11 Eli Lilly
7.11.1 Eli Lilly Details
7.11.2 Eli Lilly Major Business
7.11.3 Eli Lilly Medicinal Radiocompounds Product and Services
7.11.4 Eli Lilly Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Eli Lilly Recent Developments/Updates
7.11.6 Eli Lilly Competitive Strengths & Weaknesses
7.12 SIEMENS
7.12.1 SIEMENS Details
7.12.2 SIEMENS Major Business
7.12.3 SIEMENS Medicinal Radiocompounds Product and Services
7.12.4 SIEMENS Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 SIEMENS Recent Developments/Updates
7.12.6 SIEMENS Competitive Strengths & Weaknesses
7.13 Dongcheng
7.13.1 Dongcheng Details
7.13.2 Dongcheng Major Business
7.13.3 Dongcheng Medicinal Radiocompounds Product and Services
7.13.4 Dongcheng Medicinal Radiocompounds Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Dongcheng Recent Developments/Updates
7.13.6 Dongcheng Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Medicinal Radiocompounds Industry Chain
8.2 Medicinal Radiocompounds Upstream Analysis
8.2.1 Medicinal Radiocompounds Core Raw Materials
8.2.2 Main Manufacturers of Medicinal Radiocompounds Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Medicinal Radiocompounds Production Mode
8.6 Medicinal Radiocompounds Procurement Model
8.7 Medicinal Radiocompounds Industry Sales Model and Sales Channels
8.7.1 Medicinal Radiocompounds Sales Model
8.7.2 Medicinal Radiocompounds Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Medicinal Radiocompounds Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Medicinal Radiocompounds Production Value by Region (2018-2023) & (USD Million)
Table 3. World Medicinal Radiocompounds Production Value by Region (2024-2029) & (USD Million)
Table 4. World Medicinal Radiocompounds Production Value Market Share by Region (2018-2023)
Table 5. World Medicinal Radiocompounds Production Value Market Share by Region (2024-2029)
Table 6. World Medicinal Radiocompounds Production by Region (2018-2023) & (Tons)
Table 7. World Medicinal Radiocompounds Production by Region (2024-2029) & (Tons)
Table 8. World Medicinal Radiocompounds Production Market Share by Region (2018-2023)
Table 9. World Medicinal Radiocompounds Production Market Share by Region (2024-2029)
Table 10. World Medicinal Radiocompounds Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Medicinal Radiocompounds Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Medicinal Radiocompounds Major Market Trends
Table 13. World Medicinal Radiocompounds Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Medicinal Radiocompounds Consumption by Region (2018-2023) & (Tons)
Table 15. World Medicinal Radiocompounds Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Medicinal Radiocompounds Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Medicinal Radiocompounds Producers in 2022
Table 18. World Medicinal Radiocompounds Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Medicinal Radiocompounds Producers in 2022
Table 20. World Medicinal Radiocompounds Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Medicinal Radiocompounds Company Evaluation Quadrant
Table 22. World Medicinal Radiocompounds Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Medicinal Radiocompounds Production Site of Key Manufacturer
Table 24. Medicinal Radiocompounds Market: Company Product Type Footprint
Table 25. Medicinal Radiocompounds Market: Company Product Application Footprint
Table 26. Medicinal Radiocompounds Competitive Factors
Table 27. Medicinal Radiocompounds New Entrant and Capacity Expansion Plans
Table 28. Medicinal Radiocompounds Mergers & Acquisitions Activity
Table 29. United States VS China Medicinal Radiocompounds Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Medicinal Radiocompounds Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Medicinal Radiocompounds Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Medicinal Radiocompounds Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Medicinal Radiocompounds Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Medicinal Radiocompounds Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Medicinal Radiocompounds Production Market Share (2018-2023)
Table 37. China Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Medicinal Radiocompounds Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Medicinal Radiocompounds Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Medicinal Radiocompounds Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Medicinal Radiocompounds Production Market Share (2018-2023)
Table 42. Rest of World Based Medicinal Radiocompounds Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Medicinal Radiocompounds Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Medicinal Radiocompounds Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Medicinal Radiocompounds Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Medicinal Radiocompounds Production Market Share (2018-2023)
Table 47. World Medicinal Radiocompounds Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Medicinal Radiocompounds Production by Type (2018-2023) & (Tons)
Table 49. World Medicinal Radiocompounds Production by Type (2024-2029) & (Tons)
Table 50. World Medicinal Radiocompounds Production Value by Type (2018-2023) & (USD Million)
Table 51. World Medicinal Radiocompounds Production Value by Type (2024-2029) & (USD Million)
Table 52. World Medicinal Radiocompounds Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Medicinal Radiocompounds Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Medicinal Radiocompounds Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Medicinal Radiocompounds Production by Application (2018-2023) & (Tons)
Table 56. World Medicinal Radiocompounds Production by Application (2024-2029) & (Tons)
Table 57. World Medicinal Radiocompounds Production Value by Application (2018-2023) & (USD Million)
Table 58. World Medicinal Radiocompounds Production Value by Application (2024-2029) & (USD Million)
Table 59. World Medicinal Radiocompounds Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Medicinal Radiocompounds Average Price by Application (2024-2029) & (US$/Ton)
Table 61. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 62. Bracco Imaging Major Business
Table 63. Bracco Imaging Medicinal Radiocompounds Product and Services
Table 64. Bracco Imaging Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bracco Imaging Recent Developments/Updates
Table 66. Bracco Imaging Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer Medicinal Radiocompounds Product and Services
Table 70. Bayer Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Cardinal Health Basic Information, Manufacturing Base and Competitors
Table 74. Cardinal Health Major Business
Table 75. Cardinal Health Medicinal Radiocompounds Product and Services
Table 76. Cardinal Health Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Cardinal Health Recent Developments/Updates
Table 78. Cardinal Health Competitive Strengths & Weaknesses
Table 79. Curium Pharma Basic Information, Manufacturing Base and Competitors
Table 80. Curium Pharma Major Business
Table 81. Curium Pharma Medicinal Radiocompounds Product and Services
Table 82. Curium Pharma Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Curium Pharma Recent Developments/Updates
Table 84. Curium Pharma Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Medicinal Radiocompounds Product and Services
Table 88. Novartis Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Lantheus Basic Information, Manufacturing Base and Competitors
Table 92. Lantheus Major Business
Table 93. Lantheus Medicinal Radiocompounds Product and Services
Table 94. Lantheus Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Lantheus Recent Developments/Updates
Table 96. Lantheus Competitive Strengths & Weaknesses
Table 97. Acrotech Biopharma Basic Information, Manufacturing Base and Competitors
Table 98. Acrotech Biopharma Major Business
Table 99. Acrotech Biopharma Medicinal Radiocompounds Product and Services
Table 100. Acrotech Biopharma Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Acrotech Biopharma Recent Developments/Updates
Table 102. Acrotech Biopharma Competitive Strengths & Weaknesses
Table 103. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. GE Healthcare Major Business
Table 105. GE Healthcare Medicinal Radiocompounds Product and Services
Table 106. GE Healthcare Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GE Healthcare Recent Developments/Updates
Table 108. GE Healthcare Competitive Strengths & Weaknesses
Table 109. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 110. China Isotope & Radiation Major Business
Table 111. China Isotope & Radiation Medicinal Radiocompounds Product and Services
Table 112. China Isotope & Radiation Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. China Isotope & Radiation Recent Developments/Updates
Table 114. China Isotope & Radiation Competitive Strengths & Weaknesses
Table 115. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 116. Jubilant Pharma Major Business
Table 117. Jubilant Pharma Medicinal Radiocompounds Product and Services
Table 118. Jubilant Pharma Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Jubilant Pharma Recent Developments/Updates
Table 120. Jubilant Pharma Competitive Strengths & Weaknesses
Table 121. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 122. Eli Lilly Major Business
Table 123. Eli Lilly Medicinal Radiocompounds Product and Services
Table 124. Eli Lilly Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Eli Lilly Recent Developments/Updates
Table 126. Eli Lilly Competitive Strengths & Weaknesses
Table 127. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 128. SIEMENS Major Business
Table 129. SIEMENS Medicinal Radiocompounds Product and Services
Table 130. SIEMENS Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. SIEMENS Recent Developments/Updates
Table 132. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 133. Dongcheng Major Business
Table 134. Dongcheng Medicinal Radiocompounds Product and Services
Table 135. Dongcheng Medicinal Radiocompounds Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Medicinal Radiocompounds Upstream (Raw Materials)
Table 137. Medicinal Radiocompounds Typical Customers
Table 138. Medicinal Radiocompounds Typical Distributors
List of Figure
Figure 1. Medicinal Radiocompounds Picture
Figure 2. World Medicinal Radiocompounds Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Medicinal Radiocompounds Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 5. World Medicinal Radiocompounds Average Price (2018-2029) & (US$/Ton)
Figure 6. World Medicinal Radiocompounds Production Value Market Share by Region (2018-2029)
Figure 7. World Medicinal Radiocompounds Production Market Share by Region (2018-2029)
Figure 8. North America Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 9. Europe Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 10. China Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 11. Japan Medicinal Radiocompounds Production (2018-2029) & (Tons)
Figure 12. Medicinal Radiocompounds Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 15. World Medicinal Radiocompounds Consumption Market Share by Region (2018-2029)
Figure 16. United States Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 17. China Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 18. Europe Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 19. Japan Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 20. South Korea Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 22. India Medicinal Radiocompounds Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Medicinal Radiocompounds by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Medicinal Radiocompounds Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Medicinal Radiocompounds Markets in 2022
Figure 26. United States VS China: Medicinal Radiocompounds Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Medicinal Radiocompounds Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Medicinal Radiocompounds Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Medicinal Radiocompounds Production Market Share 2022
Figure 30. China Based Manufacturers Medicinal Radiocompounds Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Medicinal Radiocompounds Production Market Share 2022
Figure 32. World Medicinal Radiocompounds Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Medicinal Radiocompounds Production Value Market Share by Type in 2022
Figure 34. Technetium 99
Figure 35. Fluorine 18
Figure 36. Other
Figure 37. World Medicinal Radiocompounds Production Market Share by Type (2018-2029)
Figure 38. World Medicinal Radiocompounds Production Value Market Share by Type (2018-2029)
Figure 39. World Medicinal Radiocompounds Average Price by Type (2018-2029) & (US$/Ton)
Figure 40. World Medicinal Radiocompounds Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Medicinal Radiocompounds Production Value Market Share by Application in 2022
Figure 42. Oncology
Figure 43. Cardiology
Figure 44. Others
Figure 45. World Medicinal Radiocompounds Production Market Share by Application (2018-2029)
Figure 46. World Medicinal Radiocompounds Production Value Market Share by Application (2018-2029)
Figure 47. World Medicinal Radiocompounds Average Price by Application (2018-2029) & (US$/Ton)
Figure 48. Medicinal Radiocompounds Industry Chain
Figure 49. Medicinal Radiocompounds Procurement Model
Figure 50. Medicinal Radiocompounds Sales Model
Figure 51. Medicinal Radiocompounds Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bracco Imaging
Bayer
Cardinal Health
Curium Pharma
Novartis
Lantheus
Acrotech Biopharma
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
SIEMENS
Dongcheng
jiaGou

Add To Cart

gouMai

Buy Now